These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23961652)

  • 1. [Better prognosis: when and which screening methods and immunizations in HIV-infected people].
    Härter G; Grüner B
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():32-5. PubMed ID: 23961652
    [No Abstract]   [Full Text] [Related]  

  • 2. [CD4+ lymphocytes and opportunistic infections and neoplasms in patients infected with the human immunodeficiency virus].
    Villanueva JL; Prada JL; Kindelán JM; Torre-Cisneros J
    Med Clin (Barc); 1994 Dec; 103(19):758-9. PubMed ID: 7799685
    [No Abstract]   [Full Text] [Related]  

  • 3. [CD4+ lymphocytes and opportunistic infections and neoplasms in patients infected with the human immunodeficiency virus].
    Pulido Ortega F; Carnevali-Ruiz D; Rubio García R; Costa Pérez-Herrero JR
    Med Clin (Barc); 1994 Dec; 103(19):758; author reply 759. PubMed ID: 7799684
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunizations for HIV-infected adults: indications, timing, and response.
    Spach DH
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):154-8. PubMed ID: 17237556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A changed pattern of opportunistic infections and malignancies in HIV-seropositive patients after the introduction of intensive anti-HIV-combination therapy].
    Borleffs JC; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2395-9. PubMed ID: 9864534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccination in persons with HIV: the effect of highly active antiretroviral therapy.
    Søgaard OS; Schønheyder HC; Bukh AR; Harboe ZB; Rasmussen TA; Ostergaard L; Lohse N
    AIDS; 2010 Jun; 24(9):1315-22. PubMed ID: 20559037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in natural history of opportunistic infections in HIV-infected patients.
    Schneider MM
    Neth J Med; 2000 Jul; 57(1):1-3. PubMed ID: 10862994
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in CD4 count with antitubercular therapy in HIV infected children with tuberculosis.
    Mukherjee A; Lodha R; Kabra SK
    J Trop Pediatr; 2009 Apr; 55(2):125-7. PubMed ID: 18829637
    [No Abstract]   [Full Text] [Related]  

  • 10. Discussion on the effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults.
    Thiébaut R; Eholié S; Dabis F
    AIDS; 2013 Jan; 27(1):146-7. PubMed ID: 23221429
    [No Abstract]   [Full Text] [Related]  

  • 11. First presentation for care of HIV-infected patients with low CD4 cell count in Lyon, France: risk factors and consequences for survival.
    Touré A; Khanafer N; Baratin D; Bailly F; Livrozet JM; Trepo C; Peyramond D; Touraine JL; Vanhems P
    AIDS Care; 2012; 24(10):1272-6. PubMed ID: 22416893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding may lead to overestimation of pneumococcal polysaccharide vaccine effectiveness among HIV-infected individuals.
    Sogaard OS; Lohse N; Ostergaard L
    Clin Infect Dis; 2008 Jul; 47(2):294-5; author reply 295-6. PubMed ID: 18564939
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India.
    Ghate MV; Mehendale SM; Mahajan BA; Yadav R; Brahme RG; Divekar AD; Paranjape RS
    Natl Med J India; 2000; 13(4):183-7. PubMed ID: 11002684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death.
    Kaufmann GR; Elzi L; Weber R; Furrer H; Giulieri S; Vernazza P; Bernasconi E; Hirschel B; Battegay M;
    AIDS; 2011 Feb; 25(4):441-51. PubMed ID: 21206265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
    Falcó V; Jordano Q; Cruz MJ; Len O; Ribera E; Campins M; Crespo M; Ocaña I; Rodrigo MJ; Pahissa A
    Vaccine; 2006 Mar; 24(14):2567-74. PubMed ID: 16423429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis carinii pneumonia in HIV-infected patients.
    May TA; Gruta CI; Goldschmidt RH
    Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
    [No Abstract]   [Full Text] [Related]  

  • 17. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A H1N1 in HIV-infected adults.
    Martínez E; Marcos MA; Hoyo-Ulloa I; Antón A; Sánchez M; Vilella A; Larrousse M; Pérez I; Moreno A; Trilla A; Pumarola T; Gatell JM
    HIV Med; 2011 Apr; 12(4):236-45. PubMed ID: 21255221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of Pneumocystis prophylaxis.
    Zingman BS; Grossberg R
    AIDS; 2008 Jan; 22(2):323-4; author reply 324. PubMed ID: 18097244
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
    Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
    Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.